Skip to main content

CorMedix Inc 8-K, filed Nov 12, 2026

CorMedix Inc. (CRMD)

8-K 2026-11-12 For: 2026-11-12
View Original
Added on November 12, 2026

About this 8-K

CorMedix Inc filed this 8-K on November 12, 2026.

CorMedix reported third-quarter revenue of $54.5 million, net loss of $14.7 million and adjusted EBITDA of $3.1 million. For its pending Heron asset acquisition, a term loan provides up to $150 million, with $75 million expected at closing. AI summary

Items reported

  • Item 2.02: Financial results
  • Item 9.01: Financial statements and exhibits